Journal of Viral Hepatitis

Substitution rate of the hepatitis B virus surface gene
pp. 239-245(7)
Authors: Zaaijer, H. L.; Bouter, S.; Boot, H. J.

Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis
pp. 246-249(4)
Authors: Biasiolo, A.; Chemello, L.; Quarta, S.; Cavalletto, L.; Bortolotti, F.; Caberlotto, C.; Beneduce, L.; Bernardinello, E.; Tono, N.; Fassina, G.; Gatta, A.; Pontisso, P.

Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial
pp. 250-254(5)
Authors: Hickman, M.; McDonald, T.; Judd, Ali; Nichols, T.; Hope, V.; Skidmore, S.; Parry, J. V.

Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors
pp. 255-260(6)
Authors: Bani-Sadr, F.; Lapidus, N.; Melchior, J.-C.; Ravaux, I.; Bensalem, M.; Rosa, I.; Cacoub, P.; Pol, S.; Perronne, C.; Carrat, F.

Methamphetamine enhances Hepatitis C virus replication in human hepatocytes
pp. 261-270(10)
Authors: Ye, L.; Peng, J. S.; Wang, X.; Wang, Y. J.; Luo, G. X.; Ho, W. Z.

Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management
pp. 271-278(8)
Authors: Thomson, B. J.; Kwong, G.; Ratib, S.; Sweeting, M.; Ryder, S. D.; De Angelis, D.; Grieve, R.; Irving, W. L.

Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review
pp. 279-292(14)
Authors: De, P.; Roy, É.; Boivin, J.-F.; Cox, J.; Morissette, C.

Economic impact of extended treatment with peginterferon α-2a and ribavirin for slow hepatitis C virologic responders
pp. 293-299(7)
Authors: Nakamura, J.; Toyabe, S.-I.; Aoyagi, Y.; Akazawa, K.

The use of different Peg-interferon α-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response
pp. 300-304(5)
Authors: Napoli, N.; Giannelli, G.; Antonaci, A.; Antonaci, S.

Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication
pp. 305-313(9)
Authors: Kang, S. M.; Choi, S. H.; Park, C. Y.; Kim, M. H.; Kim, T. K.; Park, J. M.; Koh, M. S.; Kang, H. J.; Hwang, S. B.

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
pp. 314-321(8)
Authors: Yurdaydın, C.; Bozkaya, H.; Önder, F. O.; Şentürk, H.; Karaaslan, H.; Akdoğan, M.; Çetinkaya, H.; Erden, E.; Erkan-Esin, Ö.; Yalçın, K.; Bozdayı, A. M.; Schinazi, R. F.; Gerin, J. L.; Uzunalimoğlu, Ö.; Özden, A.